Corporate ActionAug 5, 2026, 05:34 PM
Veraxa Biotech Secures $27.5M Note, $50M Share Purchase
AI Summary
Veraxa Biotech Holding AG detailed recent capital-raising activities and share issuances. Key events include securing a $27.5 million senior secured note and a warrant from High Trail Affiliated Entities, and an agreement with Lincoln Park Capital Fund, LLC for up to $50.0 million in Ordinary Share purchases. The company also issued 3.5 million Ordinary Shares to Cantor Fitzgerald & Co. as part of a fee modification and completed a business combination involving the issuance of over 130 million new PubCo Ordinary Shares.
Key Highlights
- Secured $27.5 million senior secured note and a four-year warrant from High Trail Affiliated Entities on May 27, 2026.
- Warrant issued in High Trail Financing reflects 2,391,305 Ordinary Shares with an initial exercise price of $11.50 per share.
- Entered a purchase agreement with Lincoln Park Capital Fund, LLC on May 27, 2026, for up to $50.0 million of Ordinary Shares.
- Issued 340,910 Commitment Shares to Lincoln Park on July 30, 2026, as consideration for their commitment.
- Issued 3,500,000 Ordinary Shares to Cantor Fitzgerald & Co. on July 30, 2026, as part of a modified deferred fee.
- Issued 130,000,128 new PubCo Ordinary Shares to legacy Veraxa Biotech AG shareholders in a business combination at an 8.81293 exchange ratio.
- Issued 7,665,000 Private Warrants at $1.00 each on August 8, 2024, generating $7.665 million.
Price Impact
More from VRXA